Viper ULTRA Thrombolysis Catheter
アン ultra infusion catheter specialized for direct thrombolytic delivery, featuring multi-hole design to uniformly distribute drugs across large clot segments.
について Viper® Ultrasonic Pharmacomechanical Thrombolysis System は 低侵襲 device designed to dissolve thrombi by combining targeted ultrasonic waves with controlled tPA infusion. By thinning fibrin そして increasing clot porosity, the system enables deeper drug penetration into the thrombus, thereby enhancing the efficacy of pharmacological therapy. This approach helps mitigate potential bleeding complications そして preserves vessel integrity, offering a more refined, patient-centric strategy for acute thrombosis management.
Ultrasonic Wave Delivery
- Controlled Ultrasound: Low-power ultrasonic energy focuses on fibrin disruption, loosening the structural integrity of the clot.
- Enhanced Porosity: Breaking fibrin strands encourages tPA to penetrate deeper, ensuring thorough thrombus dissolution.
Pharmacomechanical Infusion
- tPA Administration: A site-specific delivery of tissue plasminogen activator (tPA) directly into the clot.
- Synergistic Effect: Ultrasonic micro-cavitation augments the fibrinolytic effect, requiring lower drug doses and potentially reducing hemorrhagic complications.
Gentle Mechanization
- Minimal Vessel Trauma: Ultrasonic waves are calibrated to avoid damaging valves, vessel walls, or critical structures within the venous or pulmonary vasculature.
- Reduced Bleeding Risk: Lower overall drug usage and localized infusion can curtail systemic side effects.
- Controlled Ultrasound: Low-power ultrasonic energy focuses on fibrin disruption, loosening the structural integrity of the clot.
- Enhanced Porosity: Breaking fibrin strands encourages tPA to penetrate deeper, ensuring thorough thrombus dissolution.
- tPA Administration: A site-specific delivery of tissue plasminogen activator (tPA) directly into the clot.
- Synergistic Effect: Ultrasonic micro-cavitation augments the fibrinolytic effect, requiring lower drug doses and potentially reducing hemorrhagic complications.
- Minimal Vessel Trauma: Ultrasonic waves are calibrated to avoid damaging valves, vessel walls, or critical structures within the venous or pulmonary vasculature.
- Reduced Bleeding Risk: Lower overall drug usage and localized infusion can curtail systemic side effects.
製品仕様
仕様 | 詳細 / 価値 |
製品名 | Viper ULTRA Thrombolysis Catheter |
使用目的 | Catheter-directed infusion of thrombolytics in acute or subacute thrombus (peripheral, venous, or arterial) |
カテーテルのデザイン | Multi-hole distal segment for uniform drug dispersion, possible radiopaque marker at tip |
素材 | Pebax/Polyamide shaft, potentially braided or reinforced |
外径(F) | ~4–6F (depending on infusion lumen capacity) |
作業長 | ~80–150 cm (varies by product code) |
Infusion Ports | Distributed side ports over a defined segment for consistent thrombolytic delivery |
ガイドワイヤーの適合性 | Typically 0.014” or 0.018” |
不妊症 | 滅菌済み、シングルユース |
賞味期限 | ~2–3 years if stored at 15–25 °C in sealed packaging |
臨床適応症 | Thrombolytic infusion for DVT, peripheral arterial occlusions, possibly for intra-graft thrombosis |
禁忌事項 | Highly calcified lesions, severe vessel tortuosity preventing safe passage, known device material allergies |
オーダー&サイズマトリックス
外径(F) | 作業長 (cm) | Infusion Segment (cm) | 商品コード | 備考 |
4F | 80 | 10 | VPR-4F-80-10 | Smaller OD for distal or small vessel usage |
4F | 120 | 15 | VPR-4F-120-15 | Longer shaft, moderate infusion segment |
5F | 80 | 10 | VPR-5F-80-10 | Slightly larger OD for heavier clot load |
5F | 120 | 20 | VPR-5F-120-20 | Extended length with longer infusion zone |
6F | 100 | 15 | VPR-6F-100-15 | Common size for multi-level peripheral lesions |
6F | 150 | 30 | VPR-6F-150-30 | Max length, extensive infusion segment |